Growel Formulations Enters Poultry Sector with Strategic Investment in Provet Pharma

Growel Formulations to Invest in Provet Pharma Private Limited

Growel Formulations Pvt Ltd, an India-based aqua healthcare and nutrition company, has announced a strategic investment in Provet Pharma Private Limited, a poultry healthcare and nutrition company. Although the exact sum of the investment was not disclosed, this move marks Growel Formulations' entry into the high-growth poultry segment, expanding its footprint across animal species nutrition and healthcare.

Provet Pharma, founded in 2009 by Dr V Muthu Selvan and Dr S Senthil, has established a strong presence in preventive and therapeutic solutions for poultry and aqua segments. The company has a steady pan-India sales and distribution team in place and has recently forayed into exports.

The strategic investment will significantly broaden Growel Formulations' portfolio beyond aquaculture, aligning with the company's long-term vision of building a diversified, science-led platform focused on animal nutrition, health, and wellness. Deloitte India Corporate Finance acted as the buy-side advisor to Growel Formulations, while Veda Corporate Advisors advised Provet Pharma on the deal.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

The combined platform is expected to strengthen its value proposition and expand its comprehensive portfolio of solutions to farmers and integrators across both poultry and aqua segments. This partnership is expected to further drive growth in the high-growth poultry segment, driven by rising protein needs and awareness, improved feed technology, and increasing focus on animal health and productivity.

Key Statistics:

• ₹80-100 crore: Planned investment by Growel Group over the next five years for its pet food venture
• 2009: Year Provet Pharma was founded
• 2024: Year Growel Group launched two pet treats as part of its foray into the pet food segment